FDA Issues Safety Alert Regarding Reports of SCC in Scar Tissue Around Surrounding Implants

On September 08, 2022, the Food and Drug Administration (FDA) issued a warning for patients and health specialists after it […]

September 15, 2022

FDA Approves First Targeted Therapy to Treat HER2-Low Breast Cancer

On August 05, 2022, the U.S. FDA approved Enhertu (T-DXd) or (trastuzumab deruxtecan), an IV infusion to treat patients with […]

August 9, 2022

FDA Has Granted Enhertu Breakthrough Therapy Designation (BTD) for Adult Patients with Unresectable/Metastatic HER2 +Ve Breast Cancer

The Food and Drug Administration has granted Enhertu (trastuzumab deruxtecan) Breakthrough Therapy Designation (BTD) in the US to treat adult […]

October 7, 2021

5-Minutes Novel Breast Cancer Treatment Rolled Out in UK by National Health Service

A novel breast cancer jab will lessen the time period patients have to pass in hospital from two-and-a-half hours to […]

April 8, 2021

Role of surgery for the treatment of Metastatic Breast Cancer

According to a study, “the importance of surgery together with the systemic treatments or with systemic treatments and radiation therapy […]

February 26, 2021

List of effective medications for Breast Cancer treatment

Being the most frequently occurring cancer in women, nearly 2.1 million women are diagnosed with breast cancer every year. Due […]

December 8, 2020